News Focus
News Focus
icon url

DewDiligence

02/17/16 10:31 AM

#199755 RE: Bickema #199754

4Q15 US Angiomax sales by MDCO were $18.7M; however, MDCO received $29.4M from NVS for its 4Q15 profit share of NVS’ Angiomax authorized generic. MDCO is no longer promoting the branded drug.